Xenon Pharmaceuticals, Inc. (XENE)
55.24
-0.17
(-0.31%)
USD |
NASDAQ |
Apr 24, 16:00
54.51
-0.73
(-1.32%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap : 5.271B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals, Inc. | 2.125B |
| Oncolytics Biotech, Inc. | 119.61M |
| Edesa Biotech, Inc. | 60.50M |
| Lexaria Bioscience Corp. | 23.39M |
| ProMIS Neurosciences, Inc. | 24.19M |
Market Cap Related Metrics
| PS Ratio | 583.73 |
| PEG Ratio | -0.2816 |
| Price to Book Value | 9.061 |
| Price | 55.24 |
| Earnings Yield | -7.89% |
| PEGY Ratio | -0.2816 |